DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2b689e/major_pharmaceutic) has announced the addition of the "Major Pharmaceutical Markets of the Middle East 2nd Edition: An Overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE" report to their offering.
Middle East Pharmaceutical Market Expected to Grow by 15% Annually, says New Report
The pharmaceutical market in the Middle East is likely to grow by between ten and 15 percent annually over the next three years, outstripping more mature markets, forecasts a report from URCH Publishing.
Major Pharmaceutical Markets of the Middle East (2nd Ed): An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE, says that massive growth is being forecast for the pharmaceutical and biotechnology markets of Middle Eastern states, driven by moves to liberalise national economies, the introduction of mass health insurance and the determination of the region's governments to become self-sufficient in pharmaceuticals production.
The population of the Middle East now exceeds 370 million and is expected to reach over 520 million by 2030. The growing population, dominated mainly by the expatriate community in most of the Gulf Corporation Council (GCC) countries, has given rise to a rapidly growing market for healthcare and its associated industries, which is estimated at $75bn in the Middle East alone.
This best-selling report provides the necessary background information for a firm to operate in the region.
Five key findings
- Overall the Middle East's pharmaceutical market is valued at more than $12bn and is expected to grow at healthy 10-15% annually.
- There are more than 450 pharmaceutical manufacturers in the Middle East - With the exception of Egypt, all Middle Eastern countries are high importers of branded drugs. Egypt is over 90% self-sufficient in its medicine needs
- Countries are increasingly adopting liberal economic policies in the healthcare sector
- Local manufacturing capabilities are constrained to generics.
- A high acceptance of Western medicines is present
Countries Covered:
- Egypt
- Israel
- Jordan
- Lebanon
- Saudi Arabia
- United Arab Emirates
For more information visit http://www.researchandmarkets.com/research/2b689e/major_pharmaceutic
Source: Spectra Intelligence